Capgemini SE | Large-cap | Technology

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 25.7B
Total Liabilities 13.9B
Shareholders Equity 11.8B
Debt to Equity 1.18

Cash Flow Metrics

Revenue & Profitability Trend

Capgemini SE Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i22.1B22.5B22.0B18.2B15.8B
Cost of Goods Sold i16.0B16.5B16.2B13.4B11.7B
Gross Profit i6.1B6.0B5.8B4.8B4.1B
Gross Margin % i27.4%26.9%26.5%26.4%26.1%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i3.1B3.1B3.0B2.5B2.3B
Other Operating Expenses i46.0M49.0M36.0M194.0M150.0M
Total Operating Expenses i3.2B3.1B3.0B2.6B2.4B
Operating Income i2.5B2.6B2.6B2.1B1.8B
Operating Margin % i11.5%11.5%11.6%11.3%11.1%
Non-Operating Items
Interest Income i207.0M171.0M65.0M24.0M48.0M
Interest Expense i183.0M186.0M157.0M178.0M178.0M
Other Non-Operating Income-----
Pre-tax Income i2.4B2.3B2.3B1.7B1.4B
Income Tax i681.0M626.0M710.0M526.0M400.0M
Effective Tax Rate % i28.7%27.2%31.4%31.3%29.5%
Net Income i1.7B1.7B1.6B1.2B955.0M
Net Margin % i7.6%7.4%7.0%6.4%6.0%
Key Metrics
EBITDA i3.4B3.4B3.3B2.7B2.4B
EPS (Basic) i-€9.70€9.09€6.87€5.71
EPS (Diluted) i-€9.37€8.79€6.66€5.55
Basic Shares Outstanding i-171350138170251066168574058167620101
Diluted Shares Outstanding i-171350138170251066168574058167620101

Income Statement Trend

Capgemini SE Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i2.8B3.5B3.8B3.1B2.8B
Short-term Investments i268.0M161.0M386.0M385.0M338.0M
Accounts Receivable i3.2B3.3B3.3B3.1B2.7B
Inventory i-----
Other Current Assets63.0M61.0M76.0M67.0M91.0M
Total Current Assets i9.3B9.7B10.3B9.0B7.8B
Non-Current Assets
Property, Plant & Equipment i2.1B2.0B1.8B1.7B1.6B
Goodwill i25.5B23.2B23.1B22.3B20.7B
Intangible Assets i837.0M798.0M906.0M1.0B1.1B
Long-term Investments67.0M73.0M65.0M75.0M32.0M
Other Non-Current Assets42.0M32.0M35.0M54.0M30.0M
Total Non-Current Assets i16.4B15.0B15.1B15.0B14.1B
Total Assets i25.7B24.7B25.5B24.0B22.0B
Liabilities
Current Liabilities
Accounts Payable i1.6B1.5B1.7B1.6B1.2B
Short-term Debt i1.1B926.0M1.4B361.0M1.2B
Current Portion of Long-term Debt-----
Other Current Liabilities237.0M182.0M316.0M175.0M124.0M
Total Current Liabilities i7.7B7.2B8.1B6.5B6.0B
Non-Current Liabilities
Long-term Debt i5.0B5.7B6.2B7.3B7.8B
Deferred Tax Liabilities i267.0M275.0M308.0M294.0M230.0M
Other Non-Current Liabilities352.0M376.0M471.0M466.0M417.0M
Total Non-Current Liabilities i6.2B7.0B7.7B9.0B9.9B
Total Liabilities i13.9B14.2B15.7B15.6B15.8B
Equity
Common Stock i1.4B1.4B1.4B1.4B1.4B
Retained Earnings i7.2B5.6B4.6B3.5B1.7B
Treasury Stock i-237.0M---
Other Equity-----
Total Shareholders Equity i11.8B10.5B9.7B8.5B6.1B
Key Metrics
Total Debt i6.1B6.6B7.5B7.6B9.0B
Working Capital i1.6B2.5B2.3B2.5B1.9B

Balance Sheet Composition

Capgemini SE Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i1.7B1.7B1.6B1.2B955.0M
Depreciation & Amortization i-----
Stock-Based Compensation i273.0M252.0M164.0M125.0M93.0M
Working Capital Changes i-263.0M-152.0M-308.0M178.0M79.0M
Operating Cash Flow i1.6B1.8B1.5B1.6B1.2B
Investing Activities
Capital Expenditures i-310.0M-254.0M-283.0M-262.0M-204.0M
Acquisitions i-827.0M-343.0M-204.0M-369.0M-1.6B
Investment Purchases i-----150.0M
Investment Sales i-----
Investing Cash Flow i-1.3B-383.0M-659.0M-678.0M-1.9B
Financing Activities
Share Repurchases i-989.0M-876.0M-826.0M-197.0M-514.0M
Dividends Paid i-584.0M-559.0M-409.0M-329.0M-226.0M
Debt Issuance i847.0M1.9B468.0M137.0M9.3B
Debt Repayment i-1.4B-2.9B-482.0M-1.8B-6.3B
Financing Cash Flow i-1.6B-1.8B-677.0M-2.2B672.0M
Free Cash Flow i2.2B2.3B2.2B2.3B1.5B
Net Change in Cash i-1.3B-458.0M137.0M-1.3B17.0M

Cash Flow Trend

Capgemini SE Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 13.73
Forward P/E 10.10
Price to Book 1.89
Price to Sales 0.97
PEG Ratio 10.10

Profitability Ratios

Profit Margin 7.07%
Operating Margin 10.31%
Return on Equity 14.32%
Return on Assets 6.24%

Financial Health

Current Ratio 1.11
Debt to Equity 55.23
Beta 0.92

Per Share Data

EPS (TTM) €8.87
Book Value per Share €64.56
Revenue per Share €130.03

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
cap21.7B13.731.8914.32%7.07%55.23
Sopra Steria 3.2B11.501.6014.37%4.76%63.80
Alten S.A 2.3B12.261.038.78%4.50%16.78
Wavestone S.A 1.2B15.181.8112.60%8.01%12.75
Neurones S.A 992.4M18.992.5412.05%6.10%0.10
Atos SE 943.7M0.09-31.04%17.29%3.52

Financial data is updated regularly. All figures are in the company's reporting currency.